- Study: Whooping cough vaccine may not prevent infection
- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Eat Well, Test Well: Bayer HealthCare and dLife Healthcare Solutions launch diabetes resource
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
- Reports: Bill to extend federal regulations for compounding pharmacies expected to pass House, Senate
WAYNE, N.J. — Bayer HealthCare Pharmaceuticals sought to reassure healthcare professionals and their patients that a recall of alcohol prep pads distributed with its multiple sclerosis drug did not affect the drug itself.
The drug maker’s MS treatment Betaseron (interferon beta-1b) is distributed with prep pads made by Triad Group, which recently staged a recall of prep products due to potential contamination with Bacillus cereus bacteria, which would lead to life-threatening infections.
Bayer said the contamination was confined to the prep pads and that the Betaseron itself was still safe to use. The company is urging patients to use alternative prep pads not subject to the recall.